We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection

By LabMedica International staff writers
Posted on 08 Apr 2025

Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. More...

While traditional detection methods are effective, they often lack the ability to provide spatiotemporal data on the release of viral genome material. In a significant breakthrough, researchers have developed a novel, label-free ratiometric fluorosensor that selectively and sensitively detects enteroviral RNA. This advancement paves the way for even more efficient detection methods and highlights the importance of interdisciplinary collaboration in addressing global health challenges.

Fluorescent nanoparticles have become powerful tools in bioanalyte sensing, with carbon dots (CDs) leading the charge due to their ease of synthesis, remarkable photostability, tunable photoluminescence, excellent solubility in water, biocompatibility, and versatile surface functionalities for ligand conjugation. These properties make CDs a transformative force in biosensing. At the Nanoscience Center (NSC) at the University of Jyväskylä (Jyväskylä, Finland), researchers have developed an enhanced ratiometric fluorosensor by functionalizing CDs with a Probe (a single-stranded complementary oligonucleotide fragment) and ethidium bromide (EB) for detecting enteroviral RNA. This effort, combining expertise in biology, chemistry, and physics, represents a significant advancement in viral detection technology.

The newly developed Functionalized Sensor (Func Sensor), where the CDs are covalently bonded with the probe, outperforms the traditional Non-Functionalized Sensor (Non-Func Sensor), which is a simple mix of CDs, the probe, and EB. In both sensor types, the target DNA enhances EB fluorescence upon hybridizing with the probe, while the CDs' fluorescence changes slightly due to electron transfer, enabling ratiometric detection. The Non-Func Sensor showed lower sensitivity to target DNA and was ineffective with actual enteroviral RNA samples. In contrast, the Func Sensor demonstrated much higher sensitivity to both DNA and real viral RNA, showing improved selectivity. The improved performance of the Func Sensor is attributed to enhanced charge transfer facilitated by the covalent functionalization of the CDs.

The proof-of-principle study, published in CARBON, emphasizes the significance of covalently immobilizing the probe to improve electron transfer between the CDs and EB, thereby enhancing performance. This research also demonstrates the Func Sensor’s suitability for practical applications in rapid, real-time, and precise in situ detection of viral RNA. Specifically, the study shows that the Func Sensor can detect enteroviral RNA release from the capsid in real time in vitro. This capability positions the Func Sensor as a novel platform for detecting viral RNA during infection, offering a critical advancement in real-time viral RNA detection. The team’s pioneering work not only provides a new method for viral RNA detection but also contributes valuable insights into charge transfer mechanisms between fluorophores. Building on this success, the team is now working to improve the system’s robustness by replacing the potentially harmful ethidium bromide with safer, less cytotoxic, or biocompatible dyes, further enhancing the safety and effectiveness of in vivo viral RNA detection.

Related Links:
University of Jyväskylä


New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Online QC Software
Acusera 24•7
Automatic CLIA Analyzer
Shine i6000
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The two new tests are used with the LightCycler 480 and LightCycler PRO instruments (Photo courtesy of Roche)

New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance

Cyclospora cayetanensis, a food- and waterborne intestinal parasite, can cause prolonged diarrhea, fatigue, and abdominal cramping, placing added strain on urgent care and emergency departments during outbreaks.... Read more

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.